A Form 4 filed on September 1, 2026 reports that Julie Person, Chief People Officer of Aura Biosciences, Inc. (NASDAQ:AURA), received an inducement RSU award and a stock option grant on September 1, 2026.
Key Highlights
- RSU Award: Julie Person acquired 107,611 shares of Common Stock via an inducement RSU grant at a price of $0, with direct ownership of 107,611 shares following the transaction.
- Stock Option Grant: Person also acquired a stock option to purchase 212,389 shares of Common Stock at an exercise price of $7.43, with an expiration date of September 1, 2036.
- RSU Vesting Schedule: The RSUs vest in four substantially equal annual installments, with the first tranche scheduled to vest on September 15, 2027, subject to continued service.
- Option Vesting Schedule: 25% of the options vest on August 12, 2027, with the remainder vesting pro-rata in 36 monthly installments thereafter, subject to continued service.
- Inducement Award: The RSUs were described as an inducement award granted pursuant to an RSU award agreement with the issuer.
Aura Biosciences Chief People Officer Granted RSUs and Stock Options on Joining
According to the Form 4 filed with the SEC, Julie Person, serving as Chief People Officer of Aura Biosciences, Inc., received two separate equity grants on September 1, 2026. The filing identifies Person's address as c/o Aura Biosciences, Inc., 80 Guest Street, Boston, Massachusetts 02135, and confirms the form was filed by one reporting person.
The first grant, reported in Table I of the filing, consists of 107,611 restricted stock units classified as an acquisition (Code A) at a price of $0. The filing states these securities "represent an inducement award granted pursuant to a restricted stock unit ('RSU') award agreement with the Issuer," with each RSU representing the right to receive one share of Common Stock. Following this transaction, Person directly holds 107,611 shares of Common Stock.
The second grant, reported in Table II, is a stock option with the right to buy 212,389 shares of Common Stock at an exercise price of $7.43 per share, expiring on September 1, 2036. The option vesting schedule provides that 25% of the options vest on August 12, 2027, with the remaining 75% vesting pro-rata in 36 monthly installments thereafter, in each case subject to the reporting person's continued service. The price of the derivative security is listed as $0, and Person directly holds 212,389 options following this transaction. The form was signed by Amy Elazzouzi as Attorney-in-Fact on September 1, 2026.
What Was Disclosed
The filing discloses that Aura Biosciences Chief People Officer Julie Person received an inducement RSU award for 107,611 shares and a stock option covering 212,389 shares at $7.43, both granted on September 1, 2026, with vesting contingent on continued service.




Please wait processing your request...